Clinical Trial Update: Thalidomide for Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for thalidomide in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED